| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 51 | 2024 | 1655 | 8.900 |
Why?
|
| Regeneration | 34 | 2022 | 1506 | 6.030 |
Why?
|
| Thioredoxins | 22 | 2023 | 201 | 5.310 |
Why?
|
| Heart | 33 | 2022 | 4390 | 4.420 |
Why?
|
| Myocardium | 45 | 2022 | 4680 | 4.170 |
Why?
|
| Growth Differentiation Factors | 12 | 2023 | 99 | 3.690 |
Why?
|
| Regenerative Medicine | 9 | 2022 | 308 | 2.710 |
Why?
|
| Myostatin | 6 | 2023 | 127 | 2.650 |
Why?
|
| Bone Morphogenetic Proteins | 11 | 2023 | 840 | 2.600 |
Why?
|
| Arrestins | 6 | 2023 | 73 | 2.410 |
Why?
|
| Carrier Proteins | 22 | 2016 | 4939 | 2.230 |
Why?
|
| Stem Cell Transplantation | 9 | 2022 | 1603 | 1.650 |
Why?
|
| Muscle, Smooth, Vascular | 16 | 2011 | 1483 | 1.630 |
Why?
|
| Interleukins | 10 | 2019 | 780 | 1.610 |
Why?
|
| Induced Pluripotent Stem Cells | 7 | 2024 | 1845 | 1.590 |
Why?
|
| Pluripotent Stem Cells | 5 | 2021 | 791 | 1.460 |
Why?
|
| Cardiomegaly | 7 | 2015 | 592 | 1.450 |
Why?
|
| Myocardial Reperfusion Injury | 6 | 2013 | 479 | 1.440 |
Why?
|
| Arteriosclerosis | 13 | 2005 | 1062 | 1.360 |
Why?
|
| Myocardial Infarction | 39 | 2018 | 11888 | 1.290 |
Why?
|
| Animals | 171 | 2024 | 167838 | 1.270 |
Why?
|
| Receptors, Cell Surface | 13 | 2013 | 2822 | 1.190 |
Why?
|
| Stem Cells | 17 | 2021 | 3525 | 1.140 |
Why?
|
| Mechanotransduction, Cellular | 9 | 2010 | 530 | 1.130 |
Why?
|
| Gene Deletion | 9 | 2019 | 2667 | 1.110 |
Why?
|
| Neovascularization, Physiologic | 10 | 2011 | 1336 | 1.080 |
Why?
|
| Signal Transduction | 36 | 2024 | 23362 | 1.070 |
Why?
|
| Mice | 99 | 2024 | 81138 | 1.070 |
Why?
|
| Aging | 15 | 2022 | 8634 | 1.040 |
Why?
|
| Stress, Mechanical | 27 | 2012 | 1666 | 1.040 |
Why?
|
| Cell Differentiation | 21 | 2024 | 11476 | 0.980 |
Why?
|
| Receptors, Interleukin-1 | 4 | 2009 | 261 | 0.960 |
Why?
|
| Receptors, Adrenergic, beta | 2 | 2017 | 241 | 0.900 |
Why?
|
| Lamin Type A | 6 | 2009 | 187 | 0.880 |
Why?
|
| Heart Diseases | 9 | 2017 | 2800 | 0.870 |
Why?
|
| Glucose | 8 | 2023 | 4361 | 0.860 |
Why?
|
| Gene Expression Regulation | 23 | 2020 | 11908 | 0.840 |
Why?
|
| Mitochondria, Heart | 3 | 2013 | 229 | 0.830 |
Why?
|
| Ventricular Remodeling | 12 | 2019 | 1252 | 0.820 |
Why?
|
| Cell Nucleus | 8 | 2012 | 2911 | 0.790 |
Why?
|
| Fibrosis | 8 | 2022 | 2041 | 0.790 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2024 | 2925 | 0.770 |
Why?
|
| Paracrine Communication | 3 | 2012 | 278 | 0.760 |
Why?
|
| Cells, Cultured | 44 | 2024 | 18968 | 0.760 |
Why?
|
| Chemokine CXCL12 | 4 | 2011 | 455 | 0.750 |
Why?
|
| Glucagon | 1 | 2023 | 532 | 0.750 |
Why?
|
| Physical Conditioning, Animal | 2 | 2022 | 366 | 0.750 |
Why?
|
| Cell Proliferation | 23 | 2019 | 10440 | 0.740 |
Why?
|
| Insulin | 6 | 2023 | 6591 | 0.740 |
Why?
|
| Cardiotonic Agents | 4 | 2013 | 546 | 0.740 |
Why?
|
| Interleukin-13 Receptor alpha1 Subunit | 2 | 2017 | 22 | 0.730 |
Why?
|
| Animals, Newborn | 12 | 2018 | 2675 | 0.720 |
Why?
|
| Mice, Knockout | 27 | 2020 | 14381 | 0.710 |
Why?
|
| Insulin-Like Growth Factor I | 9 | 2017 | 1919 | 0.700 |
Why?
|
| Tissue Engineering | 6 | 2016 | 1866 | 0.700 |
Why?
|
| Endothelial Cells | 10 | 2023 | 3537 | 0.690 |
Why?
|
| Mice, Inbred C57BL | 31 | 2023 | 21981 | 0.690 |
Why?
|
| Rats | 37 | 2023 | 23694 | 0.680 |
Why?
|
| Sirtuins | 2 | 2020 | 320 | 0.680 |
Why?
|
| Tunica Intima | 3 | 2010 | 459 | 0.680 |
Why?
|
| Viscum album | 1 | 2019 | 4 | 0.670 |
Why?
|
| Bone Development | 1 | 2023 | 472 | 0.670 |
Why?
|
| Microfluidic Analytical Techniques | 5 | 2015 | 809 | 0.660 |
Why?
|
| Plant Lectins | 1 | 2019 | 103 | 0.650 |
Why?
|
| Myoblasts, Cardiac | 3 | 2013 | 21 | 0.650 |
Why?
|
| Myocardial Contraction | 6 | 2019 | 1516 | 0.650 |
Why?
|
| Protein Engineering | 4 | 2013 | 541 | 0.650 |
Why?
|
| Receptors, Interleukin | 6 | 2015 | 243 | 0.640 |
Why?
|
| Naphthyridines | 1 | 2019 | 141 | 0.630 |
Why?
|
| Hypertrophy, Left Ventricular | 8 | 2013 | 853 | 0.630 |
Why?
|
| Heart Failure | 16 | 2020 | 11833 | 0.630 |
Why?
|
| Mammals | 4 | 2017 | 1130 | 0.630 |
Why?
|
| Liver | 3 | 2023 | 7514 | 0.620 |
Why?
|
| Cell Transplantation | 3 | 2012 | 473 | 0.610 |
Why?
|
| Platelet-Derived Growth Factor | 6 | 2010 | 617 | 0.600 |
Why?
|
| Actomyosin | 1 | 2018 | 109 | 0.590 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 2018 | 87 | 0.590 |
Why?
|
| Rats, Sprague-Dawley | 21 | 2021 | 8157 | 0.590 |
Why?
|
| Dietary Sucrose | 1 | 2019 | 244 | 0.580 |
Why?
|
| Identity Crisis | 1 | 2016 | 12 | 0.570 |
Why?
|
| Adsorption | 2 | 2016 | 197 | 0.570 |
Why?
|
| Oxidative Stress | 11 | 2016 | 3106 | 0.570 |
Why?
|
| Energy Metabolism | 6 | 2020 | 2869 | 0.560 |
Why?
|
| Extracellular Space | 2 | 2018 | 565 | 0.560 |
Why?
|
| Endothelium, Vascular | 10 | 2019 | 4435 | 0.560 |
Why?
|
| Insulin Resistance | 3 | 2020 | 3959 | 0.560 |
Why?
|
| Neuregulin-1 | 3 | 2015 | 135 | 0.560 |
Why?
|
| Cell Movement | 12 | 2019 | 5209 | 0.560 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 600 | 0.550 |
Why?
|
| Integrases | 1 | 2019 | 516 | 0.550 |
Why?
|
| Peptides | 8 | 2015 | 4357 | 0.550 |
Why?
|
| Adult Stem Cells | 1 | 2018 | 221 | 0.550 |
Why?
|
| Collagenases | 5 | 2009 | 220 | 0.540 |
Why?
|
| Adipose Tissue, White | 2 | 2017 | 365 | 0.540 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2023 | 2867 | 0.540 |
Why?
|
| GATA4 Transcription Factor | 1 | 2016 | 124 | 0.530 |
Why?
|
| Receptor, Insulin | 1 | 2020 | 836 | 0.530 |
Why?
|
| Myocardial Ischemia | 5 | 2017 | 2161 | 0.520 |
Why?
|
| Cardiomyopathies | 4 | 2020 | 1940 | 0.520 |
Why?
|
| Fibroblasts | 12 | 2012 | 4084 | 0.520 |
Why?
|
| Humans | 169 | 2024 | 759255 | 0.500 |
Why?
|
| Apolipoproteins E | 4 | 2018 | 1436 | 0.500 |
Why?
|
| Membrane Proteins | 11 | 2007 | 7851 | 0.500 |
Why?
|
| Biocompatible Materials | 3 | 2011 | 1688 | 0.500 |
Why?
|
| Parabiosis | 3 | 2014 | 64 | 0.490 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2019 | 625 | 0.490 |
Why?
|
| Aortic Valve Insufficiency | 8 | 2008 | 584 | 0.490 |
Why?
|
| Disease Models, Animal | 20 | 2024 | 18110 | 0.480 |
Why?
|
| Fructose | 1 | 2016 | 287 | 0.470 |
Why?
|
| Transcription, Genetic | 5 | 2015 | 7595 | 0.470 |
Why?
|
| Echocardiography, Doppler | 11 | 2020 | 900 | 0.460 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2019 | 819 | 0.450 |
Why?
|
| Elasticity | 7 | 2010 | 652 | 0.450 |
Why?
|
| Chemical Engineering | 1 | 2013 | 15 | 0.450 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2019 | 996 | 0.440 |
Why?
|
| Neural Crest | 1 | 2016 | 279 | 0.440 |
Why?
|
| Insulin-Secreting Cells | 2 | 2018 | 903 | 0.440 |
Why?
|
| Extracellular Matrix | 7 | 2010 | 1726 | 0.440 |
Why?
|
| Arrestin | 2 | 2011 | 30 | 0.440 |
Why?
|
| Dietary Fats | 2 | 2019 | 1992 | 0.440 |
Why?
|
| Heart Ventricles | 12 | 2019 | 3802 | 0.430 |
Why?
|
| Matrix Metalloproteinases | 5 | 2014 | 392 | 0.420 |
Why?
|
| Aorta | 9 | 2005 | 2042 | 0.420 |
Why?
|
| Natriuretic Peptide, Brain | 4 | 2011 | 1705 | 0.420 |
Why?
|
| Reactive Oxygen Species | 9 | 2015 | 2135 | 0.420 |
Why?
|
| Proteins | 5 | 2021 | 6029 | 0.410 |
Why?
|
| Collagen | 8 | 2009 | 2635 | 0.410 |
Why?
|
| Stress, Physiological | 5 | 2012 | 1395 | 0.410 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2014 | 207 | 0.400 |
Why?
|
| Atherosclerosis | 3 | 2023 | 3525 | 0.390 |
Why?
|
| Immediate-Early Proteins | 4 | 2003 | 450 | 0.390 |
Why?
|
| Muscle, Skeletal | 4 | 2023 | 4922 | 0.380 |
Why?
|
| Matrix Metalloproteinase 2 | 4 | 2011 | 462 | 0.380 |
Why?
|
| Troponin T | 2 | 2018 | 774 | 0.370 |
Why?
|
| Stroke Volume | 8 | 2020 | 5497 | 0.370 |
Why?
|
| RNA, Messenger | 23 | 2012 | 12774 | 0.370 |
Why?
|
| Echocardiography | 16 | 2018 | 4971 | 0.370 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2019 | 2061 | 0.370 |
Why?
|
| Heart Injuries | 2 | 2014 | 208 | 0.350 |
Why?
|
| Drug Delivery Systems | 6 | 2017 | 2218 | 0.350 |
Why?
|
| Lamin Type B | 2 | 2007 | 26 | 0.350 |
Why?
|
| Adipogenesis | 2 | 2017 | 358 | 0.340 |
Why?
|
| Models, Cardiovascular | 6 | 2011 | 974 | 0.340 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 4 | 2005 | 1521 | 0.340 |
Why?
|
| Peptide Library | 1 | 2011 | 347 | 0.340 |
Why?
|
| Adrenomedullin | 1 | 2009 | 85 | 0.340 |
Why?
|
| Cell Survival | 11 | 2014 | 5796 | 0.330 |
Why?
|
| Apoptosis | 14 | 2019 | 9492 | 0.330 |
Why?
|
| Evolution, Molecular | 1 | 2018 | 1883 | 0.330 |
Why?
|
| Recombinant Proteins | 9 | 2020 | 6542 | 0.330 |
Why?
|
| Body Weight | 1 | 2020 | 4608 | 0.330 |
Why?
|
| Embryo, Mammalian | 3 | 2021 | 1666 | 0.310 |
Why?
|
| Epidermal Growth Factor | 2 | 2015 | 695 | 0.310 |
Why?
|
| Cardiology | 2 | 2017 | 1720 | 0.310 |
Why?
|
| DNA | 5 | 2023 | 7237 | 0.310 |
Why?
|
| Integrins | 4 | 2004 | 840 | 0.300 |
Why?
|
| Epigenesis, Genetic | 3 | 2023 | 3754 | 0.300 |
Why?
|
| Inflammation | 10 | 2023 | 10747 | 0.300 |
Why?
|
| Cell Cycle | 5 | 2016 | 2939 | 0.300 |
Why?
|
| Cytoskeleton | 4 | 2007 | 1167 | 0.300 |
Why?
|
| Receptors, CXCR4 | 2 | 2011 | 730 | 0.300 |
Why?
|
| Micromanipulation | 2 | 2004 | 52 | 0.300 |
Why?
|
| Male | 81 | 2024 | 358719 | 0.290 |
Why?
|
| Glutathione | 2 | 2007 | 582 | 0.290 |
Why?
|
| Interleukin-1 | 8 | 2003 | 1251 | 0.290 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2013 | 497 | 0.290 |
Why?
|
| Proto-Oncogene Proteins c-sis | 4 | 2016 | 256 | 0.290 |
Why?
|
| Matrix Metalloproteinase 9 | 5 | 2005 | 633 | 0.290 |
Why?
|
| Thermogenesis | 1 | 2011 | 468 | 0.280 |
Why?
|
| Peptide Fragments | 2 | 2011 | 5120 | 0.280 |
Why?
|
| MAP Kinase Kinase Kinase 5 | 1 | 2006 | 20 | 0.280 |
Why?
|
| Monocytes | 4 | 2002 | 2575 | 0.280 |
Why?
|
| Morphogenesis | 2 | 2008 | 740 | 0.280 |
Why?
|
| Hepatocytes | 2 | 2019 | 1228 | 0.280 |
Why?
|
| Oxidation-Reduction | 7 | 2023 | 2225 | 0.280 |
Why?
|
| Nitro Compounds | 1 | 2006 | 74 | 0.280 |
Why?
|
| Capillaries | 2 | 2011 | 744 | 0.280 |
Why?
|
| Doxorubicin | 1 | 2013 | 2203 | 0.270 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 2295 | 0.270 |
Why?
|
| Zebrafish | 6 | 2021 | 2996 | 0.270 |
Why?
|
| Cell Line | 12 | 2019 | 15636 | 0.270 |
Why?
|
| Ventricular Function | 3 | 2009 | 408 | 0.270 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2009 | 628 | 0.270 |
Why?
|
| NF-kappa B | 7 | 2013 | 2486 | 0.260 |
Why?
|
| Myoblasts, Skeletal | 3 | 2014 | 76 | 0.260 |
Why?
|
| Thymopoietins | 1 | 2005 | 10 | 0.260 |
Why?
|
| Hypertension | 5 | 2015 | 8594 | 0.260 |
Why?
|
| Cell Growth Processes | 1 | 2006 | 384 | 0.260 |
Why?
|
| Chemokines, CXC | 1 | 2007 | 421 | 0.260 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 2 | 2005 | 186 | 0.260 |
Why?
|
| Metalloendopeptidases | 2 | 1999 | 394 | 0.260 |
Why?
|
| Nanomedicine | 2 | 2019 | 289 | 0.260 |
Why?
|
| Adipose Tissue, Brown | 1 | 2011 | 755 | 0.260 |
Why?
|
| Multipotent Stem Cells | 2 | 2018 | 200 | 0.260 |
Why?
|
| Cytokinesis | 2 | 2018 | 172 | 0.260 |
Why?
|
| Veins | 1 | 2010 | 765 | 0.260 |
Why?
|
| Nanotubes, Peptide | 1 | 2005 | 1 | 0.250 |
Why?
|
| Cardiovascular Diseases | 7 | 2022 | 15728 | 0.250 |
Why?
|
| Blotting, Northern | 7 | 2005 | 1544 | 0.250 |
Why?
|
| Aorta, Abdominal | 4 | 2009 | 623 | 0.250 |
Why?
|
| Mitochondria | 4 | 2021 | 3600 | 0.240 |
Why?
|
| Myosin Heavy Chains | 3 | 2019 | 402 | 0.240 |
Why?
|
| Cardiac Output, Low | 1 | 2005 | 192 | 0.240 |
Why?
|
| Mesenchymal Stem Cells | 3 | 2013 | 1630 | 0.240 |
Why?
|
| Heart Valve Diseases | 4 | 2008 | 1048 | 0.240 |
Why?
|
| Amino Acid Sequence | 10 | 2017 | 13456 | 0.240 |
Why?
|
| Calcineurin | 2 | 2022 | 229 | 0.240 |
Why?
|
| Macrophages | 6 | 2005 | 5730 | 0.240 |
Why?
|
| Oxidative Phosphorylation | 2 | 2019 | 495 | 0.240 |
Why?
|
| Connexin 43 | 1 | 2005 | 200 | 0.240 |
Why?
|
| Ascorbic Acid | 2 | 2009 | 655 | 0.230 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2010 | 1655 | 0.230 |
Why?
|
| Muscle Development | 2 | 2017 | 261 | 0.230 |
Why?
|
| Gene Targeting | 1 | 2007 | 839 | 0.230 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 1997 | 590 | 0.230 |
Why?
|
| Disulfides | 1 | 2006 | 465 | 0.230 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2016 | 2755 | 0.230 |
Why?
|
| Thymidine | 2 | 2022 | 300 | 0.230 |
Why?
|
| Interleukin-4 | 4 | 2019 | 1132 | 0.230 |
Why?
|
| Receptors, Transferrin | 2 | 2004 | 291 | 0.230 |
Why?
|
| Fetal Heart | 1 | 2005 | 281 | 0.230 |
Why?
|
| Cardiovascular Agents | 1 | 2010 | 865 | 0.230 |
Why?
|
| Magnetics | 4 | 2004 | 600 | 0.230 |
Why?
|
| Adiposity | 2 | 2012 | 1848 | 0.220 |
Why?
|
| Chemokines, CC | 2 | 2004 | 283 | 0.220 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2004 | 326 | 0.220 |
Why?
|
| Heparan Sulfate Proteoglycans | 3 | 2018 | 112 | 0.220 |
Why?
|
| DNA Adducts | 1 | 2023 | 94 | 0.220 |
Why?
|
| Green Fluorescent Proteins | 6 | 2019 | 2056 | 0.220 |
Why?
|
| Phenyl Ethers | 2 | 2002 | 61 | 0.220 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 4312 | 0.220 |
Why?
|
| Diffusion of Innovation | 2 | 2020 | 730 | 0.220 |
Why?
|
| Cell Physiological Phenomena | 1 | 2004 | 150 | 0.210 |
Why?
|
| Bone Marrow Transplantation | 1 | 2011 | 2696 | 0.210 |
Why?
|
| Molecular Sequence Data | 8 | 2016 | 17629 | 0.210 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 8491 | 0.210 |
Why?
|
| Rejuvenation | 2 | 2014 | 106 | 0.210 |
Why?
|
| Sequence Alignment | 3 | 2017 | 2177 | 0.210 |
Why?
|
| Protein Structure, Tertiary | 6 | 2016 | 3800 | 0.210 |
Why?
|
| Fluorobenzenes | 1 | 2004 | 180 | 0.210 |
Why?
|
| Protein Binding | 11 | 2017 | 9334 | 0.210 |
Why?
|
| Models, Biological | 7 | 2021 | 9466 | 0.210 |
Why?
|
| Homeostasis | 4 | 2017 | 3304 | 0.210 |
Why?
|
| Drug Carriers | 1 | 2007 | 705 | 0.210 |
Why?
|
| Cholesterol, Dietary | 2 | 2001 | 224 | 0.210 |
Why?
|
| Mass Spectrometry | 3 | 2017 | 2191 | 0.210 |
Why?
|
| Heparin | 5 | 2014 | 1656 | 0.210 |
Why?
|
| Gluconeogenesis | 1 | 2023 | 185 | 0.200 |
Why?
|
| Hyperglycemia | 3 | 2007 | 1378 | 0.200 |
Why?
|
| Neoplasm Proteins | 3 | 2003 | 3613 | 0.200 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 3 | 2009 | 225 | 0.200 |
Why?
|
| Female | 51 | 2024 | 390240 | 0.200 |
Why?
|
| Phosphorylation | 5 | 2020 | 8313 | 0.200 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2003 | 239 | 0.200 |
Why?
|
| Carotid Artery Diseases | 3 | 2004 | 881 | 0.200 |
Why?
|
| Proteoglycans | 2 | 2005 | 802 | 0.200 |
Why?
|
| Blood Pressure | 8 | 2013 | 8523 | 0.200 |
Why?
|
| Diastole | 2 | 2014 | 786 | 0.190 |
Why?
|
| MicroRNAs | 3 | 2018 | 3797 | 0.190 |
Why?
|
| Lipid Metabolism | 3 | 2012 | 1902 | 0.190 |
Why?
|
| Imidazoles | 3 | 2019 | 1175 | 0.190 |
Why?
|
| Receptors, Lipoprotein | 1 | 2001 | 88 | 0.190 |
Why?
|
| Chemotaxis | 3 | 2015 | 598 | 0.190 |
Why?
|
| Mast Cells | 3 | 2019 | 1428 | 0.190 |
Why?
|
| CD40 Ligand | 1 | 2003 | 521 | 0.190 |
Why?
|
| Nitric Oxide | 2 | 2007 | 2142 | 0.180 |
Why?
|
| Vasculitis | 2 | 2005 | 524 | 0.180 |
Why?
|
| Neovascularization, Pathologic | 2 | 2008 | 2635 | 0.180 |
Why?
|
| Interleukin-13 | 3 | 2022 | 372 | 0.180 |
Why?
|
| Pressure | 5 | 2010 | 1155 | 0.180 |
Why?
|
| Polyploidy | 2 | 2012 | 119 | 0.180 |
Why?
|
| Nitric Oxide Synthase | 3 | 2004 | 908 | 0.180 |
Why?
|
| Coronary Restenosis | 1 | 2003 | 425 | 0.180 |
Why?
|
| Pesticides | 1 | 2023 | 290 | 0.180 |
Why?
|
| Receptors, LDL | 2 | 2018 | 491 | 0.180 |
Why?
|
| Ventricular Function, Left | 6 | 2019 | 3854 | 0.180 |
Why?
|
| Coronary Thrombosis | 1 | 2003 | 486 | 0.180 |
Why?
|
| Dipeptidyl Peptidase 4 | 3 | 2011 | 91 | 0.180 |
Why?
|
| Genes, Reporter | 5 | 2019 | 1532 | 0.180 |
Why?
|
| Random Allocation | 4 | 2013 | 2393 | 0.180 |
Why?
|
| Blood Glucose | 4 | 2014 | 6368 | 0.180 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2014 | 3617 | 0.180 |
Why?
|
| Toluene | 1 | 2019 | 32 | 0.170 |
Why?
|
| Transforming Growth Factor beta | 4 | 2023 | 1951 | 0.170 |
Why?
|
| Dimerization | 2 | 2016 | 890 | 0.170 |
Why?
|
| Receptor, Angiotensin, Type 1 | 4 | 2002 | 148 | 0.170 |
Why?
|
| Ligation | 4 | 2005 | 449 | 0.170 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2014 | 3732 | 0.170 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2010 | 1173 | 0.170 |
Why?
|
| Blood Flow Velocity | 5 | 2005 | 1371 | 0.170 |
Why?
|
| Enzyme Inhibitors | 5 | 2009 | 3724 | 0.170 |
Why?
|
| Blotting, Western | 7 | 2005 | 5039 | 0.170 |
Why?
|
| Embryo, Nonmammalian | 1 | 2003 | 900 | 0.170 |
Why?
|
| Microtubules | 2 | 2018 | 1072 | 0.170 |
Why?
|
| Single-Blind Method | 3 | 2013 | 1574 | 0.170 |
Why?
|
| Tenascin | 1 | 1999 | 62 | 0.170 |
Why?
|
| Transfection | 6 | 2006 | 5783 | 0.160 |
Why?
|
| Recovery of Function | 3 | 2020 | 2979 | 0.160 |
Why?
|
| Models, Molecular | 5 | 2017 | 5427 | 0.160 |
Why?
|
| Ileum | 1 | 2021 | 556 | 0.160 |
Why?
|
| Tissue Culture Techniques | 2 | 2018 | 290 | 0.160 |
Why?
|
| Structure-Activity Relationship | 3 | 2017 | 3087 | 0.160 |
Why?
|
| Forecasting | 2 | 2020 | 2931 | 0.160 |
Why?
|
| Enzyme Activation | 3 | 2020 | 3604 | 0.160 |
Why?
|
| Matrix Metalloproteinase 1 | 5 | 2003 | 141 | 0.160 |
Why?
|
| Ubiquitin | 2 | 2019 | 838 | 0.160 |
Why?
|
| Antioxidants | 3 | 2004 | 1668 | 0.160 |
Why?
|
| I-kappa B Proteins | 1 | 1999 | 212 | 0.160 |
Why?
|
| Benzothiazoles | 1 | 2019 | 246 | 0.160 |
Why?
|
| Follistatin | 2 | 2017 | 136 | 0.160 |
Why?
|
| 3T3-L1 Cells | 2 | 2011 | 209 | 0.160 |
Why?
|
| Embryonic Stem Cells | 3 | 2013 | 1268 | 0.160 |
Why?
|
| Finite Element Analysis | 3 | 2004 | 428 | 0.160 |
Why?
|
| 3T3 Cells | 3 | 2010 | 1085 | 0.160 |
Why?
|
| Indoles | 2 | 2015 | 1828 | 0.160 |
Why?
|
| Saphenous Vein | 3 | 1998 | 538 | 0.160 |
Why?
|
| Injections | 3 | 2006 | 832 | 0.150 |
Why?
|
| Cell Lineage | 1 | 2007 | 2524 | 0.150 |
Why?
|
| Genetic Engineering | 2 | 2021 | 932 | 0.150 |
Why?
|
| Imaging, Three-Dimensional | 6 | 2021 | 4040 | 0.150 |
Why?
|
| Gene Transfer Techniques | 3 | 2012 | 1204 | 0.150 |
Why?
|
| Scleroderma, Systemic | 1 | 2022 | 344 | 0.150 |
Why?
|
| Muscle Cells | 2 | 2011 | 195 | 0.150 |
Why?
|
| Muscle Proteins | 2 | 2005 | 1152 | 0.150 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 5880 | 0.150 |
Why?
|
| STAT Transcription Factors | 1 | 2018 | 188 | 0.150 |
Why?
|
| Inflammasomes | 1 | 2023 | 531 | 0.150 |
Why?
|
| Cattle | 6 | 2016 | 3844 | 0.150 |
Why?
|
| Ambystoma mexicanum | 1 | 2018 | 51 | 0.150 |
Why?
|
| Acetylation | 1 | 2020 | 1062 | 0.150 |
Why?
|
| Receptors, Chemokine | 1 | 2000 | 654 | 0.150 |
Why?
|
| Janus Kinases | 1 | 2018 | 249 | 0.140 |
Why?
|
| Angiotensin II | 4 | 2009 | 850 | 0.140 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2019 | 111 | 0.140 |
Why?
|
| Laminin | 3 | 2005 | 405 | 0.140 |
Why?
|
| Hypertension, Pulmonary | 2 | 2006 | 1567 | 0.140 |
Why?
|
| Caloric Restriction | 1 | 2019 | 295 | 0.140 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2018 | 235 | 0.140 |
Why?
|
| Coronary Disease | 4 | 2005 | 5993 | 0.140 |
Why?
|
| Giant Cells | 1 | 2017 | 185 | 0.140 |
Why?
|
| Nanostructures | 3 | 2017 | 547 | 0.140 |
Why?
|
| Tensile Strength | 2 | 1994 | 331 | 0.140 |
Why?
|
| Apoptosis Regulatory Proteins | 4 | 2009 | 1135 | 0.140 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2022 | 3072 | 0.140 |
Why?
|
| Cell Size | 4 | 2004 | 623 | 0.140 |
Why?
|
| Sialoglycoproteins | 1 | 1997 | 315 | 0.140 |
Why?
|
| Amino Acids | 1 | 2023 | 1715 | 0.140 |
Why?
|
| Wound Healing | 3 | 2008 | 2782 | 0.140 |
Why?
|
| Hypoglycemic Agents | 3 | 2020 | 3150 | 0.140 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 1998 | 354 | 0.140 |
Why?
|
| Electrocardiography | 4 | 2011 | 6400 | 0.140 |
Why?
|
| Chondroitin Sulfates | 2 | 2010 | 175 | 0.140 |
Why?
|
| Carbohydrate Metabolism | 1 | 2017 | 262 | 0.140 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 2 | 2009 | 266 | 0.130 |
Why?
|
| Chimera | 1 | 2017 | 453 | 0.130 |
Why?
|
| NAD | 1 | 2020 | 611 | 0.130 |
Why?
|
| Cell Adhesion | 5 | 2005 | 3094 | 0.130 |
Why?
|
| Mice, Transgenic | 9 | 2012 | 9528 | 0.130 |
Why?
|
| Follistatin-Related Proteins | 1 | 2016 | 48 | 0.130 |
Why?
|
| Cell Membrane | 3 | 2020 | 3683 | 0.130 |
Why?
|
| Coronary Vessels | 5 | 2009 | 3112 | 0.130 |
Why?
|
| Stem Cell Research | 1 | 2016 | 37 | 0.130 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2003 | 1880 | 0.130 |
Why?
|
| Pyrimidines | 2 | 2005 | 2996 | 0.130 |
Why?
|
| Receptor, Angiotensin, Type 2 | 3 | 2001 | 60 | 0.130 |
Why?
|
| Adrenergic Agents | 1 | 2016 | 74 | 0.130 |
Why?
|
| Carotid Arteries | 3 | 2007 | 951 | 0.130 |
Why?
|
| Vagotomy | 1 | 2015 | 83 | 0.130 |
Why?
|
| Connective Tissue Cells | 1 | 2015 | 50 | 0.130 |
Why?
|
| Nuclear Envelope | 2 | 2007 | 165 | 0.130 |
Why?
|
| Peptides, Cyclic | 1 | 2018 | 392 | 0.130 |
Why?
|
| Lysine | 1 | 2020 | 1002 | 0.130 |
Why?
|
| Protease Inhibitors | 1 | 1999 | 755 | 0.130 |
Why?
|
| Muscles | 2 | 2021 | 1582 | 0.130 |
Why?
|
| Plant Extracts | 1 | 2019 | 494 | 0.130 |
Why?
|
| Tissue Scaffolds | 3 | 2017 | 927 | 0.130 |
Why?
|
| Adenosine Triphosphate | 2 | 2012 | 1994 | 0.130 |
Why?
|
| Transcription Factors | 7 | 2016 | 12106 | 0.130 |
Why?
|
| Cell Culture Techniques | 3 | 2015 | 1666 | 0.130 |
Why?
|
| Cartilage, Articular | 2 | 2014 | 1091 | 0.120 |
Why?
|
| Species Specificity | 1 | 2019 | 2412 | 0.120 |
Why?
|
| Acetylcysteine | 3 | 2002 | 264 | 0.120 |
Why?
|
| Bone Marrow Cells | 2 | 2016 | 2424 | 0.120 |
Why?
|
| Cytokines | 5 | 2022 | 7346 | 0.120 |
Why?
|
| Protein Conformation | 3 | 2016 | 3970 | 0.120 |
Why?
|
| Cell Division | 3 | 2012 | 4463 | 0.120 |
Why?
|
| Culture Media, Serum-Free | 1 | 2014 | 151 | 0.120 |
Why?
|
| Horses | 1 | 2015 | 299 | 0.120 |
Why?
|
| Organ Specificity | 3 | 2016 | 1953 | 0.120 |
Why?
|
| Receptors, Immunologic | 1 | 2001 | 1434 | 0.120 |
Why?
|
| Sulfonamides | 1 | 2004 | 1972 | 0.120 |
Why?
|
| Mutation | 11 | 2019 | 29877 | 0.120 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 1 | 2014 | 28 | 0.120 |
Why?
|
| Tetradecanoylphorbol Acetate | 3 | 2001 | 819 | 0.120 |
Why?
|
| Interleukin-4 Receptor alpha Subunit | 1 | 2014 | 57 | 0.120 |
Why?
|
| STAT6 Transcription Factor | 1 | 2014 | 193 | 0.120 |
Why?
|
| Nanotechnology | 3 | 2017 | 708 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 1619 | 0.120 |
Why?
|
| Membrane Glycoproteins | 3 | 2002 | 3730 | 0.120 |
Why?
|
| RNA, Small Interfering | 4 | 2015 | 3443 | 0.120 |
Why?
|
| Isotope Labeling | 2 | 2012 | 388 | 0.120 |
Why?
|
| Amino Acid Substitution | 3 | 2013 | 1737 | 0.120 |
Why?
|
| Calcium Phosphates | 1 | 2015 | 171 | 0.120 |
Why?
|
| Denervation | 1 | 2015 | 277 | 0.120 |
Why?
|
| Nerve Growth Factor | 1 | 2015 | 158 | 0.120 |
Why?
|
| Calcinosis | 2 | 2001 | 1477 | 0.120 |
Why?
|
| Disease Progression | 5 | 2019 | 13479 | 0.120 |
Why?
|
| Cell Dedifferentiation | 1 | 2014 | 121 | 0.110 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2019 | 1314 | 0.110 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 1080 | 0.110 |
Why?
|
| Aortic Diseases | 2 | 2004 | 736 | 0.110 |
Why?
|
| Crosses, Genetic | 2 | 2006 | 752 | 0.110 |
Why?
|
| Sheep | 2 | 2015 | 1441 | 0.110 |
Why?
|
| Cytoplasm | 3 | 2012 | 1521 | 0.110 |
Why?
|
| Age Factors | 3 | 2019 | 18394 | 0.110 |
Why?
|
| Subcutaneous Fat | 1 | 2017 | 393 | 0.110 |
Why?
|
| Genetic Vectors | 4 | 2004 | 3377 | 0.110 |
Why?
|
| Keratinocytes | 1 | 1997 | 792 | 0.110 |
Why?
|
| Cardiotoxins | 1 | 2013 | 37 | 0.110 |
Why?
|
| Pulmonary Embolism | 3 | 1996 | 2536 | 0.110 |
Why?
|
| Snakes | 1 | 2013 | 29 | 0.110 |
Why?
|
| Amphibians | 1 | 2013 | 29 | 0.110 |
Why?
|
| Colon | 1 | 2021 | 1791 | 0.110 |
Why?
|
| Plasmids | 2 | 2009 | 2277 | 0.110 |
Why?
|
| HEK293 Cells | 4 | 2021 | 4262 | 0.110 |
Why?
|
| Tumor Burden | 1 | 2019 | 1886 | 0.110 |
Why?
|
| Norepinephrine | 1 | 2016 | 899 | 0.110 |
Why?
|
| Time Factors | 16 | 2015 | 40109 | 0.110 |
Why?
|
| Macaca mulatta | 1 | 2019 | 2315 | 0.110 |
Why?
|
| Gene Expression Profiling | 6 | 2018 | 9374 | 0.110 |
Why?
|
| Hemodynamics | 8 | 2011 | 4164 | 0.110 |
Why?
|
| Cell Respiration | 1 | 2013 | 202 | 0.110 |
Why?
|
| Angina Pectoris | 1 | 1997 | 970 | 0.110 |
Why?
|
| Aortic Valve | 4 | 1998 | 1994 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 3 | 2022 | 1612 | 0.100 |
Why?
|
| Mice, Nude | 1 | 2019 | 3605 | 0.100 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2016 | 613 | 0.100 |
Why?
|
| Cysteine Endopeptidases | 1 | 2015 | 548 | 0.100 |
Why?
|
| Proteomics | 3 | 2018 | 3804 | 0.100 |
Why?
|
| RNA | 3 | 2018 | 2723 | 0.100 |
Why?
|
| Aged | 24 | 2024 | 168617 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2011 | 10827 | 0.100 |
Why?
|
| Jurkat Cells | 2 | 2011 | 736 | 0.100 |
Why?
|
| Luminescent Proteins | 3 | 2004 | 835 | 0.100 |
Why?
|
| Glucose Clamp Technique | 2 | 2010 | 262 | 0.100 |
Why?
|
| Dendritic Cells | 1 | 2003 | 2725 | 0.100 |
Why?
|
| Islets of Langerhans | 1 | 2018 | 1340 | 0.100 |
Why?
|
| Obesity | 2 | 2011 | 12896 | 0.100 |
Why?
|
| NIH 3T3 Cells | 2 | 2012 | 671 | 0.100 |
Why?
|
| Unfolded Protein Response | 1 | 2014 | 233 | 0.100 |
Why?
|
| Cell Communication | 2 | 2010 | 1641 | 0.100 |
Why?
|
| Biomimetic Materials | 1 | 2013 | 173 | 0.100 |
Why?
|
| Anaerobiosis | 1 | 2011 | 139 | 0.100 |
Why?
|
| Immunohistochemistry | 8 | 2010 | 11058 | 0.100 |
Why?
|
| Ligands | 5 | 2019 | 3275 | 0.100 |
Why?
|
| Dermatitis, Atopic | 1 | 2019 | 710 | 0.100 |
Why?
|
| Early Growth Response Protein 1 | 2 | 2010 | 132 | 0.100 |
Why?
|
| Intestinal Mucosa | 2 | 2021 | 3021 | 0.100 |
Why?
|
| Nitric Oxide Synthase Type II | 3 | 2004 | 514 | 0.100 |
Why?
|
| Constriction, Pathologic | 3 | 2004 | 1101 | 0.100 |
Why?
|
| Colorectal Neoplasms | 2 | 2024 | 6853 | 0.100 |
Why?
|
| Nuclear Pore | 1 | 2012 | 62 | 0.100 |
Why?
|
| Iceland | 1 | 2011 | 184 | 0.100 |
Why?
|
| Food Hypersensitivity | 1 | 2019 | 692 | 0.100 |
Why?
|
| Injections, Intra-Arterial | 1 | 2011 | 182 | 0.100 |
Why?
|
| Electric Capacitance | 1 | 2010 | 14 | 0.090 |
Why?
|
| Fibronectins | 3 | 2000 | 721 | 0.090 |
Why?
|
| Lymphocytes | 1 | 2019 | 2609 | 0.090 |
Why?
|
| Guided Tissue Regeneration | 1 | 2011 | 88 | 0.090 |
Why?
|
| Middle Aged | 29 | 2024 | 219653 | 0.090 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 16871 | 0.090 |
Why?
|
| Gene Knockout Techniques | 1 | 2014 | 803 | 0.090 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2003 | 1284 | 0.090 |
Why?
|
| Piperazines | 2 | 2019 | 2517 | 0.090 |
Why?
|
| Delayed-Action Preparations | 1 | 2014 | 961 | 0.090 |
Why?
|
| Antigen-Antibody Complex | 1 | 2012 | 513 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3584 | 0.090 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 1996 | 615 | 0.090 |
Why?
|
| Halogenated Diphenyl Ethers | 2 | 2002 | 83 | 0.090 |
Why?
|
| Angiotensin Receptor Antagonists | 3 | 2002 | 1025 | 0.090 |
Why?
|
| Animals, Genetically Modified | 1 | 2015 | 1552 | 0.090 |
Why?
|
| STAT3 Transcription Factor | 1 | 2014 | 872 | 0.090 |
Why?
|
| Dependovirus | 3 | 2018 | 708 | 0.090 |
Why?
|
| Microspheres | 1 | 2013 | 786 | 0.090 |
Why?
|
| Embryoid Bodies | 1 | 2010 | 68 | 0.090 |
Why?
|
| Mice, Inbred Strains | 3 | 2004 | 1766 | 0.090 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2023 | 1183 | 0.090 |
Why?
|
| Electric Impedance | 2 | 2010 | 750 | 0.090 |
Why?
|
| Mutation, Missense | 2 | 2011 | 2559 | 0.090 |
Why?
|
| Interleukin-6 | 2 | 2001 | 3205 | 0.090 |
Why?
|
| Colitis | 1 | 2019 | 1230 | 0.090 |
Why?
|
| Receptor, erbB-3 | 1 | 2011 | 143 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2011 | 385 | 0.090 |
Why?
|
| Hematopoiesis | 1 | 2019 | 2063 | 0.090 |
Why?
|
| Protein Multimerization | 1 | 2015 | 981 | 0.090 |
Why?
|
| Matrix Metalloproteinase 3 | 3 | 2003 | 138 | 0.090 |
Why?
|
| Angiogenic Proteins | 1 | 2010 | 101 | 0.090 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2011 | 345 | 0.090 |
Why?
|
| Cell Transdifferentiation | 1 | 2011 | 185 | 0.090 |
Why?
|
| Adult | 15 | 2024 | 219390 | 0.090 |
Why?
|
| Crystallization | 2 | 2014 | 534 | 0.090 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 1993 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 5 | 2013 | 5789 | 0.090 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2009 | 3333 | 0.090 |
Why?
|
| Intercellular Junctions | 1 | 2010 | 197 | 0.090 |
Why?
|
| Rupture, Spontaneous | 2 | 2003 | 356 | 0.090 |
Why?
|
| Microtomy | 1 | 2009 | 44 | 0.080 |
Why?
|
| Calcium Signaling | 1 | 2014 | 731 | 0.080 |
Why?
|
| Alleles | 2 | 2019 | 6897 | 0.080 |
Why?
|
| Gels | 2 | 2005 | 419 | 0.080 |
Why?
|
| Radiometric Dating | 1 | 2009 | 10 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2014 | 3600 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2004 | 3329 | 0.080 |
Why?
|
| Calcium-Binding Proteins | 1 | 2014 | 1066 | 0.080 |
Why?
|
| Cell Nucleus Division | 1 | 2009 | 12 | 0.080 |
Why?
|
| Protein Stability | 1 | 2011 | 566 | 0.080 |
Why?
|
| Stem Cell Niche | 1 | 2013 | 346 | 0.080 |
Why?
|
| Membranes | 2 | 2007 | 165 | 0.080 |
Why?
|
| Chondrocytes | 1 | 2014 | 791 | 0.080 |
Why?
|
| Immunity | 1 | 2015 | 998 | 0.080 |
Why?
|
| Ubiquitination | 1 | 2014 | 1009 | 0.080 |
Why?
|
| Nuclear Weapons | 1 | 2009 | 13 | 0.080 |
Why?
|
| Desmin | 1 | 2009 | 99 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2013 | 10333 | 0.080 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2009 | 141 | 0.080 |
Why?
|
| Synaptic Transmission | 1 | 2015 | 1169 | 0.080 |
Why?
|
| Tryptases | 1 | 2010 | 177 | 0.080 |
Why?
|
| Parkinson Disease | 1 | 2023 | 2843 | 0.080 |
Why?
|
| Receptors, Notch | 1 | 2014 | 742 | 0.080 |
Why?
|
| Progeria | 2 | 2008 | 188 | 0.080 |
Why?
|
| Kidney | 1 | 2004 | 7066 | 0.080 |
Why?
|
| Linkage Disequilibrium | 2 | 2011 | 1995 | 0.080 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 2 | 2000 | 151 | 0.080 |
Why?
|
| Hindlimb | 1 | 2011 | 510 | 0.080 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 2003 | 1128 | 0.080 |
Why?
|
| Gene Regulatory Networks | 2 | 2014 | 1738 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2019 | 3390 | 0.080 |
Why?
|
| Benzofurans | 1 | 2009 | 142 | 0.080 |
Why?
|
| Smoking | 1 | 2005 | 9066 | 0.080 |
Why?
|
| Arterioles | 2 | 2011 | 250 | 0.080 |
Why?
|
| Amino Acid Motifs | 1 | 2011 | 929 | 0.080 |
Why?
|
| Neurotransmitter Agents | 2 | 2003 | 661 | 0.080 |
Why?
|
| Phenotype | 4 | 2020 | 16532 | 0.080 |
Why?
|
| Proteome | 1 | 2018 | 1849 | 0.080 |
Why?
|
| Chromatin | 1 | 2020 | 2939 | 0.080 |
Why?
|
| Cell Adhesion Molecules | 1 | 2014 | 1600 | 0.080 |
Why?
|
| Tissue Plasminogen Activator | 1 | 1994 | 1189 | 0.080 |
Why?
|
| Biotin | 1 | 2009 | 253 | 0.080 |
Why?
|
| Drug Combinations | 2 | 2024 | 2023 | 0.080 |
Why?
|
| Farnesyltranstransferase | 1 | 2008 | 71 | 0.080 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2013 | 1132 | 0.080 |
Why?
|
| Adenoviridae | 2 | 2002 | 1084 | 0.080 |
Why?
|
| Regional Blood Flow | 2 | 2006 | 1490 | 0.080 |
Why?
|
| Chromatography, Affinity | 1 | 2009 | 535 | 0.080 |
Why?
|
| Endoplasmic Reticulum | 1 | 2014 | 1135 | 0.080 |
Why?
|
| Telomere | 1 | 2014 | 934 | 0.080 |
Why?
|
| Ultrasonography | 8 | 2006 | 5955 | 0.080 |
Why?
|
| Predictive Value of Tests | 7 | 2003 | 15264 | 0.070 |
Why?
|
| Carbon Radioisotopes | 1 | 2009 | 557 | 0.070 |
Why?
|
| Microscopy, Video | 2 | 2007 | 242 | 0.070 |
Why?
|
| Ketosis | 1 | 2007 | 46 | 0.070 |
Why?
|
| Myosins | 2 | 2003 | 405 | 0.070 |
Why?
|
| Physical Stimulation | 3 | 2004 | 518 | 0.070 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 2007 | 74 | 0.070 |
Why?
|
| DNA Replication | 1 | 2014 | 1413 | 0.070 |
Why?
|
| Glycolysis | 1 | 2011 | 828 | 0.070 |
Why?
|
| Neurogenesis | 1 | 2014 | 854 | 0.070 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2007 | 93 | 0.070 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2010 | 380 | 0.070 |
Why?
|
| Body Composition | 1 | 2017 | 2414 | 0.070 |
Why?
|
| Genomics | 1 | 2003 | 5775 | 0.070 |
Why?
|
| Materials Testing | 2 | 2014 | 857 | 0.070 |
Why?
|
| Prostheses and Implants | 1 | 1994 | 1274 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2011 | 729 | 0.070 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2009 | 1200 | 0.070 |
Why?
|
| Hyperinsulinism | 1 | 2010 | 398 | 0.070 |
Why?
|
| Autophagy | 1 | 2015 | 1336 | 0.070 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2019 | 2128 | 0.070 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2006 | 56 | 0.070 |
Why?
|
| Thioredoxin-Disulfide Reductase | 1 | 2006 | 44 | 0.070 |
Why?
|
| Analysis of Variance | 4 | 2009 | 6242 | 0.070 |
Why?
|
| Image Cytometry | 1 | 2007 | 53 | 0.070 |
Why?
|
| Models, Animal | 2 | 2010 | 2118 | 0.070 |
Why?
|
| Cholesterol | 3 | 2005 | 2923 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2004 | 36160 | 0.070 |
Why?
|
| Neural Stem Cells | 1 | 2014 | 884 | 0.070 |
Why?
|
| Hyperplasia | 1 | 2010 | 1158 | 0.070 |
Why?
|
| Survival Analysis | 5 | 2008 | 10185 | 0.070 |
Why?
|
| Antigens, CD | 3 | 2003 | 4000 | 0.070 |
Why?
|
| Rabbits | 3 | 2005 | 4772 | 0.070 |
Why?
|
| Muscular Dystrophies | 1 | 2009 | 386 | 0.070 |
Why?
|
| Systole | 2 | 1999 | 947 | 0.070 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2006 | 689 | 0.070 |
Why?
|
| Osteoarthritis | 1 | 2014 | 1055 | 0.070 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2001 | 829 | 0.070 |
Why?
|
| Nuclear Lamina | 1 | 2006 | 47 | 0.070 |
Why?
|
| Treatment Outcome | 9 | 2017 | 64879 | 0.070 |
Why?
|
| Palliative Care | 1 | 2021 | 3606 | 0.070 |
Why?
|
| RNA Interference | 1 | 2014 | 2847 | 0.070 |
Why?
|
| Biotinylation | 1 | 2006 | 179 | 0.070 |
Why?
|
| Hedgehog Proteins | 1 | 2010 | 769 | 0.070 |
Why?
|
| Sensitivity and Specificity | 9 | 2013 | 14652 | 0.070 |
Why?
|
| Protein Precursors | 2 | 2010 | 1135 | 0.070 |
Why?
|
| Muscular Dystrophy, Emery-Dreifuss | 1 | 2005 | 21 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2003 | 3774 | 0.060 |
Why?
|
| Protein Kinase C | 2 | 2002 | 1201 | 0.060 |
Why?
|
| Pericytes | 1 | 2008 | 291 | 0.060 |
Why?
|
| Heparitin Sulfate | 2 | 2010 | 224 | 0.060 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2013 | 684 | 0.060 |
Why?
|
| Methionine | 1 | 2008 | 569 | 0.060 |
Why?
|
| Multivariate Analysis | 5 | 2003 | 12152 | 0.060 |
Why?
|
| Comorbidity | 3 | 2019 | 10547 | 0.060 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2005 | 121 | 0.060 |
Why?
|
| Coculture Techniques | 2 | 2010 | 1335 | 0.060 |
Why?
|
| Biodegradation, Environmental | 1 | 2005 | 218 | 0.060 |
Why?
|
| alpha-Fetoproteins | 1 | 2005 | 221 | 0.060 |
Why?
|
| Chemokine CCL11 | 2 | 2004 | 128 | 0.060 |
Why?
|
| Dystroglycans | 1 | 2004 | 62 | 0.060 |
Why?
|
| Free Radical Scavengers | 2 | 2009 | 211 | 0.060 |
Why?
|
| Troponin I | 1 | 2009 | 634 | 0.060 |
Why?
|
| Coronary Artery Bypass | 2 | 2010 | 2274 | 0.060 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2005 | 144 | 0.060 |
Why?
|
| Oxidants | 1 | 2005 | 169 | 0.060 |
Why?
|
| Hydrogels | 2 | 2014 | 725 | 0.060 |
Why?
|
| Adolescent | 5 | 2019 | 87560 | 0.060 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2003 | 613 | 0.060 |
Why?
|
| Interferon-gamma | 3 | 2004 | 3161 | 0.060 |
Why?
|
| Peptide Hydrolases | 1 | 2007 | 623 | 0.060 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2004 | 133 | 0.060 |
Why?
|
| Computer Simulation | 4 | 2013 | 6195 | 0.060 |
Why?
|
| Lipid Peroxidation | 1 | 2005 | 271 | 0.060 |
Why?
|
| Hydrogen Bonding | 1 | 2004 | 291 | 0.060 |
Why?
|
| Focal Adhesions | 1 | 2004 | 115 | 0.060 |
Why?
|
| DNA, Complementary | 2 | 2005 | 1993 | 0.060 |
Why?
|
| Autoimmunity | 1 | 2012 | 1370 | 0.060 |
Why?
|
| Membrane Fluidity | 1 | 2003 | 68 | 0.060 |
Why?
|
| Neoplasms | 2 | 2024 | 22019 | 0.060 |
Why?
|
| Sex Factors | 2 | 2011 | 10518 | 0.060 |
Why?
|
| Cerebrovascular Circulation | 1 | 2014 | 2725 | 0.060 |
Why?
|
| Reproducibility of Results | 7 | 2009 | 20031 | 0.060 |
Why?
|
| Cell Cycle Proteins | 2 | 2006 | 3449 | 0.060 |
Why?
|
| Integrin alpha6beta1 | 1 | 2003 | 19 | 0.060 |
Why?
|
| Autocrine Communication | 1 | 2004 | 169 | 0.060 |
Why?
|
| Exercise | 1 | 2020 | 5773 | 0.060 |
Why?
|
| Phenylephrine | 1 | 2004 | 293 | 0.060 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2005 | 279 | 0.060 |
Why?
|
| Solubility | 2 | 2003 | 1087 | 0.060 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2004 | 280 | 0.050 |
Why?
|
| Nuclease Protection Assays | 1 | 2002 | 15 | 0.050 |
Why?
|
| Clinical Trials as Topic | 3 | 2016 | 8055 | 0.050 |
Why?
|
| Carotid Artery Injuries | 1 | 2003 | 96 | 0.050 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2024 | 295 | 0.050 |
Why?
|
| Phorbol Esters | 1 | 2002 | 108 | 0.050 |
Why?
|
| Amlodipine | 1 | 2003 | 84 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2006 | 1168 | 0.050 |
Why?
|
| Nuclear Proteins | 3 | 2008 | 5793 | 0.050 |
Why?
|
| Pyridines | 2 | 2006 | 2875 | 0.050 |
Why?
|
| Heart Conduction System | 2 | 2005 | 1015 | 0.050 |
Why?
|
| Hyperlipidemias | 1 | 2007 | 782 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2004 | 5870 | 0.050 |
Why?
|
| Caspase 1 | 1 | 2003 | 226 | 0.050 |
Why?
|
| Muscular Atrophy | 1 | 2005 | 331 | 0.050 |
Why?
|
| Aorta, Thoracic | 2 | 2000 | 1094 | 0.050 |
Why?
|
| Heterozygote | 2 | 2006 | 2796 | 0.050 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2004 | 465 | 0.050 |
Why?
|
| Actinin | 1 | 2003 | 161 | 0.050 |
Why?
|
| Rodentia | 1 | 2023 | 260 | 0.050 |
Why?
|
| Ischemia | 1 | 2011 | 1893 | 0.050 |
Why?
|
| Double-Blind Method | 4 | 2005 | 12386 | 0.050 |
Why?
|
| Electricity | 1 | 2023 | 182 | 0.050 |
Why?
|
| Gene Expression | 3 | 2013 | 7593 | 0.050 |
Why?
|
| Survival Rate | 5 | 2004 | 12800 | 0.050 |
Why?
|
| Genetic Loci | 1 | 2011 | 2617 | 0.050 |
Why?
|
| Nerve Fibers | 1 | 2005 | 708 | 0.050 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2003 | 350 | 0.050 |
Why?
|
| Young Adult | 2 | 2019 | 58483 | 0.050 |
Why?
|
| Prognosis | 9 | 2011 | 29561 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 2 | 2006 | 2651 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2004 | 704 | 0.050 |
Why?
|
| Enoxaparin | 1 | 2004 | 397 | 0.050 |
Why?
|
| Superoxide Dismutase | 1 | 2004 | 593 | 0.050 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2001 | 84 | 0.050 |
Why?
|
| Chromatography, Agarose | 1 | 2001 | 29 | 0.050 |
Why?
|
| Biglycan | 1 | 2001 | 10 | 0.050 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2001 | 52 | 0.050 |
Why?
|
| Cardiovascular System | 1 | 2009 | 849 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2007 | 1611 | 0.050 |
Why?
|
| Cysteine | 1 | 2006 | 892 | 0.050 |
Why?
|
| Cancer Care Facilities | 1 | 2024 | 424 | 0.050 |
Why?
|
| Versicans | 1 | 2001 | 40 | 0.050 |
Why?
|
| Injections, Intra-Articular | 2 | 2014 | 280 | 0.050 |
Why?
|
| Decorin | 1 | 2001 | 38 | 0.050 |
Why?
|
| Cardiac Volume | 1 | 2002 | 199 | 0.050 |
Why?
|
| Fasting | 1 | 2007 | 1603 | 0.050 |
Why?
|
| Transduction, Genetic | 1 | 2004 | 898 | 0.050 |
Why?
|
| Receptors, Scavenger | 1 | 2001 | 122 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2002 | 435 | 0.050 |
Why?
|
| Receptors, CCR3 | 1 | 2000 | 61 | 0.050 |
Why?
|
| Bleomycin | 1 | 2022 | 496 | 0.050 |
Why?
|
| Ramipril | 2 | 2001 | 97 | 0.050 |
Why?
|
| Pregnancy | 1 | 2023 | 29658 | 0.050 |
Why?
|
| DNA Primers | 1 | 2005 | 2817 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2005 | 3804 | 0.050 |
Why?
|
| Vitamins | 1 | 2009 | 1634 | 0.050 |
Why?
|
| Bioprosthesis | 1 | 2005 | 599 | 0.050 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2005 | 694 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2019 | 4132 | 0.050 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2001 | 141 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2002 | 555 | 0.050 |
Why?
|
| Dilatation, Pathologic | 1 | 2002 | 523 | 0.040 |
Why?
|
| Equipment Design | 3 | 2015 | 3529 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2005 | 4360 | 0.040 |
Why?
|
| Infant | 1 | 2022 | 35941 | 0.040 |
Why?
|
| RNA Stability | 1 | 2002 | 336 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2003 | 1760 | 0.040 |
Why?
|
| 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt | 1 | 1999 | 5 | 0.040 |
Why?
|
| Necrosis | 1 | 2004 | 1613 | 0.040 |
Why?
|
| Genes, Immediate-Early | 1 | 2000 | 101 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2023 | 985 | 0.040 |
Why?
|
| Coronary Artery Disease | 2 | 2017 | 6649 | 0.040 |
Why?
|
| Osteonectin | 1 | 1999 | 33 | 0.040 |
Why?
|
| Image Enhancement | 2 | 2009 | 2878 | 0.040 |
Why?
|
| Lung | 3 | 2006 | 9982 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 4573 | 0.040 |
Why?
|
| Losartan | 1 | 2001 | 258 | 0.040 |
Why?
|
| Skin | 3 | 2022 | 4467 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 2003 | 691 | 0.040 |
Why?
|
| Endopeptidases | 1 | 2003 | 772 | 0.040 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2024 | 894 | 0.040 |
Why?
|
| Heat-Shock Proteins | 1 | 2003 | 796 | 0.040 |
Why?
|
| Larva | 1 | 2021 | 509 | 0.040 |
Why?
|
| Peripheral Arterial Disease | 1 | 2011 | 1310 | 0.040 |
Why?
|
| Protein Isoforms | 2 | 2006 | 1695 | 0.040 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2000 | 282 | 0.040 |
Why?
|
| Serum Amyloid A Protein | 1 | 1999 | 127 | 0.040 |
Why?
|
| Homozygote | 2 | 2019 | 1786 | 0.040 |
Why?
|
| Binding Sites | 1 | 2008 | 6053 | 0.040 |
Why?
|
| Catalase | 1 | 1999 | 216 | 0.040 |
Why?
|
| Follow-Up Studies | 4 | 2008 | 39216 | 0.040 |
Why?
|
| Th2 Cells | 1 | 2004 | 1048 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2019 | 17750 | 0.040 |
Why?
|
| Blood Vessels | 1 | 2004 | 1112 | 0.040 |
Why?
|
| Papillary Muscles | 1 | 1999 | 192 | 0.040 |
Why?
|
| Child | 4 | 2019 | 79623 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2002 | 733 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2006 | 1972 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 1746 | 0.040 |
Why?
|
| Acute Coronary Syndrome | 1 | 2011 | 2363 | 0.040 |
Why?
|
| Brain | 2 | 2016 | 26863 | 0.040 |
Why?
|
| Electrophysiology | 1 | 2001 | 1265 | 0.040 |
Why?
|
| I-kappa B Kinase | 1 | 1999 | 251 | 0.040 |
Why?
|
| Receptors, Angiotensin | 1 | 1998 | 141 | 0.040 |
Why?
|
| Growth Differentiation Factor 2 | 1 | 2018 | 27 | 0.040 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 1998 | 63 | 0.040 |
Why?
|
| Cycloheximide | 1 | 1998 | 343 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2004 | 8929 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2004 | 1756 | 0.040 |
Why?
|
| Scattering, Small Angle | 1 | 2018 | 63 | 0.040 |
Why?
|
| Cohort Studies | 3 | 2011 | 41247 | 0.040 |
Why?
|
| Pulmonary Artery | 1 | 2006 | 1910 | 0.040 |
Why?
|
| Perception | 1 | 2024 | 1189 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2004 | 1106 | 0.040 |
Why?
|
| Lipoproteins, LDL | 1 | 2001 | 641 | 0.040 |
Why?
|
| Tryptophan | 1 | 2019 | 480 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2004 | 1512 | 0.040 |
Why?
|
| Indazoles | 1 | 1999 | 302 | 0.040 |
Why?
|
| Lipopolysaccharides | 2 | 2002 | 2213 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2001 | 591 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2012 | 3438 | 0.040 |
Why?
|
| DNA-Binding Proteins | 4 | 2007 | 9590 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 1247 | 0.040 |
Why?
|
| Hyaluronic Acid | 1 | 2001 | 482 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2008 | 3478 | 0.040 |
Why?
|
| Structural Homology, Protein | 1 | 2017 | 86 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 1998 | 311 | 0.040 |
Why?
|
| Prospective Studies | 8 | 2013 | 54204 | 0.030 |
Why?
|
| Ventricular Dysfunction | 1 | 1997 | 145 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 1408 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2001 | 854 | 0.030 |
Why?
|
| Biological Transport | 1 | 2021 | 2086 | 0.030 |
Why?
|
| Chronic Disease | 4 | 2019 | 9282 | 0.030 |
Why?
|
| Base Sequence | 2 | 2005 | 12450 | 0.030 |
Why?
|
| Smad Proteins | 1 | 2017 | 158 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 2 | 2013 | 321 | 0.030 |
Why?
|
| Activins | 1 | 2018 | 210 | 0.030 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 1997 | 298 | 0.030 |
Why?
|
| Health Status | 2 | 2001 | 4079 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 2017 | 531 | 0.030 |
Why?
|
| Cyclohexylamines | 1 | 2015 | 20 | 0.030 |
Why?
|
| Coronary Angiography | 1 | 2008 | 4560 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2013 | 15750 | 0.030 |
Why?
|
| Homocysteine | 1 | 1999 | 640 | 0.030 |
Why?
|
| Calcium | 2 | 2015 | 5721 | 0.030 |
Why?
|
| Adipocytes | 2 | 2017 | 1179 | 0.030 |
Why?
|
| Gelatinases | 1 | 1995 | 88 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 1999 | 1705 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2011 | 3416 | 0.030 |
Why?
|
| Myoblasts | 1 | 2017 | 235 | 0.030 |
Why?
|
| Neural Tube | 1 | 2015 | 48 | 0.030 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 301 | 0.030 |
Why?
|
| Neuroglia | 1 | 2021 | 944 | 0.030 |
Why?
|
| Organoids | 1 | 2021 | 729 | 0.030 |
Why?
|
| Carotid Stenosis | 1 | 2003 | 872 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1998 | 587 | 0.030 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 1995 | 186 | 0.030 |
Why?
|
| Observer Variation | 2 | 1999 | 2596 | 0.030 |
Why?
|
| Luciferases | 1 | 2017 | 717 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 1999 | 1849 | 0.030 |
Why?
|
| Societies, Scientific | 1 | 2016 | 221 | 0.030 |
Why?
|
| Thrombolytic Therapy | 1 | 2004 | 2107 | 0.030 |
Why?
|
| Myeloid Cells | 1 | 2019 | 818 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2002 | 2920 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2017 | 1388 | 0.030 |
Why?
|
| Sex Characteristics | 2 | 2003 | 2627 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2013 | 5630 | 0.030 |
Why?
|
| Rats, Inbred F344 | 2 | 2009 | 825 | 0.030 |
Why?
|
| Stainless Steel | 1 | 1994 | 79 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 1996 | 522 | 0.030 |
Why?
|
| Trachea | 1 | 2000 | 1082 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 1999 | 1091 | 0.030 |
Why?
|
| Precipitin Tests | 1 | 1995 | 815 | 0.030 |
Why?
|
| Shear Strength | 2 | 2005 | 161 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 2019 | 1166 | 0.030 |
Why?
|
| Fibrinolytic Agents | 1 | 2004 | 2168 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2021 | 1334 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2011 | 12874 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2004 | 6496 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2018 | 1233 | 0.030 |
Why?
|
| Sarcomeres | 2 | 2009 | 367 | 0.030 |
Why?
|
| Drosophila | 1 | 2021 | 1491 | 0.030 |
Why?
|
| Electric Stimulation | 2 | 2001 | 1736 | 0.030 |
Why?
|
| Fourier Analysis | 1 | 1994 | 438 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2004 | 2416 | 0.030 |
Why?
|
| Risk Factors | 6 | 2004 | 74167 | 0.030 |
Why?
|
| Antibodies | 1 | 2001 | 2423 | 0.030 |
Why?
|
| Ventricular Pressure | 1 | 1994 | 204 | 0.030 |
Why?
|
| Videotape Recording | 1 | 1994 | 337 | 0.030 |
Why?
|
| Actins | 1 | 2000 | 2048 | 0.030 |
Why?
|
| Kinetics | 1 | 2001 | 6380 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2010 | 10181 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2018 | 2509 | 0.030 |
Why?
|
| Olfactory Bulb | 1 | 2014 | 198 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 1994 | 662 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2019 | 1493 | 0.030 |
Why?
|
| Cardiac Tamponade | 1 | 1994 | 174 | 0.030 |
Why?
|
| Atrophy | 1 | 2018 | 1625 | 0.030 |
Why?
|
| Tretinoin | 1 | 2015 | 522 | 0.030 |
Why?
|
| Diffusion | 1 | 2014 | 813 | 0.030 |
Why?
|
| Italy | 1 | 1994 | 840 | 0.030 |
Why?
|
| Acute Disease | 3 | 2003 | 7262 | 0.030 |
Why?
|
| Oligopeptides | 1 | 1998 | 1187 | 0.030 |
Why?
|
| Rats, Inbred Lew | 1 | 2014 | 1154 | 0.030 |
Why?
|
| Rupture | 1 | 1994 | 442 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2017 | 1978 | 0.030 |
Why?
|
| Rotation | 1 | 1994 | 514 | 0.030 |
Why?
|
| Isotopes | 1 | 2012 | 125 | 0.020 |
Why?
|
| Human Growth Hormone | 1 | 2017 | 638 | 0.020 |
Why?
|
| Reference Values | 1 | 2019 | 4918 | 0.020 |
Why?
|
| Mitral Valve Insufficiency | 2 | 1998 | 1420 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2001 | 2256 | 0.020 |
Why?
|
| Templates, Genetic | 1 | 2012 | 190 | 0.020 |
Why?
|
| Anaphylaxis | 1 | 2019 | 753 | 0.020 |
Why?
|
| Vascular Patency | 1 | 1994 | 904 | 0.020 |
Why?
|
| Genome | 1 | 2019 | 1739 | 0.020 |
Why?
|
| Chondroitinases and Chondroitin Lyases | 1 | 2010 | 15 | 0.020 |
Why?
|
| Chi-Square Distribution | 2 | 1994 | 3468 | 0.020 |
Why?
|
| Thiophenes | 1 | 2015 | 587 | 0.020 |
Why?
|
| Cell Count | 1 | 2015 | 1837 | 0.020 |
Why?
|
| Lymphopoiesis | 1 | 2012 | 133 | 0.020 |
Why?
|
| Polysaccharide-Lyases | 1 | 2010 | 47 | 0.020 |
Why?
|
| Surface Properties | 1 | 1994 | 1158 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2004 | 3193 | 0.020 |
Why?
|
| Chest Pain | 2 | 1997 | 1106 | 0.020 |
Why?
|
| Nanofibers | 1 | 2011 | 66 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2019 | 41935 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2005 | 4491 | 0.020 |
Why?
|
| Motor Neurons | 1 | 2015 | 864 | 0.020 |
Why?
|
| Enterocytes | 1 | 2012 | 220 | 0.020 |
Why?
|
| Acetanilides | 1 | 2011 | 169 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2011 | 265 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2012 | 476 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 6218 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2004 | 5414 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 1999 | 1698 | 0.020 |
Why?
|
| Ventricular Function, Right | 1 | 1994 | 610 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 2015 | 815 | 0.020 |
Why?
|
| ROC Curve | 2 | 1994 | 3570 | 0.020 |
Why?
|
| Mesoderm | 1 | 2013 | 672 | 0.020 |
Why?
|
| Lipids | 1 | 2001 | 3336 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2015 | 1327 | 0.020 |
Why?
|
| Oxypurinol | 1 | 2009 | 8 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 1994 | 2235 | 0.020 |
Why?
|
| Informed Consent | 1 | 2016 | 1008 | 0.020 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 1996 | 1030 | 0.020 |
Why?
|
| Tissue Survival | 1 | 2009 | 118 | 0.020 |
Why?
|
| alpha-Crystallin B Chain | 1 | 2009 | 24 | 0.020 |
Why?
|
| Medical Oncology | 1 | 2021 | 2311 | 0.020 |
Why?
|
| Compliance | 1 | 2009 | 100 | 0.020 |
Why?
|
| Drug Design | 1 | 2014 | 1062 | 0.020 |
Why?
|
| Receptors, IgG | 1 | 2012 | 565 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2013 | 581 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2005 | 15815 | 0.020 |
Why?
|
| Xanthine Oxidase | 1 | 2009 | 69 | 0.020 |
Why?
|
| Cell Fusion | 1 | 2009 | 293 | 0.020 |
Why?
|
| Canada | 1 | 1994 | 2124 | 0.020 |
Why?
|
| Hemorheology | 1 | 2009 | 144 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 1994 | 2932 | 0.020 |
Why?
|
| Algorithms | 1 | 2009 | 13946 | 0.020 |
Why?
|
| Blood Coagulation | 1 | 1994 | 1152 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2004 | 4897 | 0.020 |
Why?
|
| Diagnostic Tests, Routine | 1 | 1994 | 784 | 0.020 |
Why?
|
| COS Cells | 1 | 2010 | 1129 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2003 | 5066 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2009 | 295 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2009 | 693 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2013 | 1187 | 0.020 |
Why?
|
| Intranuclear Space | 1 | 2007 | 15 | 0.020 |
Why?
|
| Qb-SNARE Proteins | 1 | 2007 | 34 | 0.020 |
Why?
|
| Consensus | 1 | 2017 | 3095 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 1999 | 3823 | 0.020 |
Why?
|
| Elastin | 1 | 2009 | 300 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1994 | 1488 | 0.020 |
Why?
|
| Prevalence | 1 | 2024 | 15641 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 9194 | 0.020 |
Why?
|
| Polymers | 1 | 1994 | 1618 | 0.020 |
Why?
|
| Connective Tissue | 1 | 2009 | 417 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2007 | 191 | 0.020 |
Why?
|
| Heart Valve Prosthesis | 1 | 1995 | 1494 | 0.020 |
Why?
|
| Histological Techniques | 1 | 2006 | 193 | 0.020 |
Why?
|
| Melanoma | 1 | 2004 | 5692 | 0.020 |
Why?
|
| Incidence | 1 | 2004 | 21336 | 0.020 |
Why?
|
| Intestine, Small | 1 | 2012 | 1206 | 0.020 |
Why?
|
| Postoperative Complications | 2 | 2001 | 15672 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2007 | 401 | 0.020 |
Why?
|
| Myosin Light Chains | 1 | 2005 | 121 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2009 | 1755 | 0.020 |
Why?
|
| Protein Folding | 1 | 2009 | 867 | 0.020 |
Why?
|
| Histones | 1 | 2015 | 2582 | 0.020 |
Why?
|
| Aged, 80 and over | 4 | 2008 | 58867 | 0.020 |
Why?
|
| Immune System | 1 | 2010 | 795 | 0.010 |
Why?
|
| Aortic Valve Stenosis | 1 | 1997 | 2066 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2006 | 871 | 0.010 |
Why?
|
| Paxillin | 1 | 2004 | 86 | 0.010 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2005 | 174 | 0.010 |
Why?
|
| Odds Ratio | 1 | 1997 | 9711 | 0.010 |
Why?
|
| Equipment Failure Analysis | 1 | 2007 | 848 | 0.010 |
Why?
|
| Receptors, Interferon | 1 | 2004 | 116 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2009 | 1345 | 0.010 |
Why?
|
| Compressive Strength | 1 | 2004 | 157 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 2712 | 0.010 |
Why?
|
| Bisbenzimidazole | 1 | 2003 | 13 | 0.010 |
Why?
|
| Leukocytes | 1 | 2012 | 2030 | 0.010 |
Why?
|
| Constriction | 1 | 2003 | 171 | 0.010 |
Why?
|
| Autoantibodies | 1 | 2012 | 2116 | 0.010 |
Why?
|
| Pulsatile Flow | 1 | 2004 | 319 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2005 | 444 | 0.010 |
Why?
|
| Viscosity | 1 | 2003 | 335 | 0.010 |
Why?
|
| Extracellular Fluid | 1 | 2004 | 165 | 0.010 |
Why?
|
| Glucose Intolerance | 1 | 2007 | 579 | 0.010 |
Why?
|
| Muscle Weakness | 1 | 2006 | 413 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2007 | 12268 | 0.010 |
Why?
|
| Mechanoreceptors | 1 | 2004 | 187 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2012 | 1709 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2009 | 1295 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2010 | 2203 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2008 | 2642 | 0.010 |
Why?
|
| United States | 2 | 2024 | 72237 | 0.010 |
Why?
|
| Logistic Models | 1 | 1997 | 13309 | 0.010 |
Why?
|
| Interleukin-18 | 1 | 2003 | 251 | 0.010 |
Why?
|
| Skull | 1 | 2006 | 815 | 0.010 |
Why?
|
| Mitosis | 1 | 2006 | 1195 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2001 | 2253 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2003 | 778 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2003 | 561 | 0.010 |
Why?
|
| Cicatrix | 1 | 2006 | 782 | 0.010 |
Why?
|
| Calibration | 1 | 2003 | 816 | 0.010 |
Why?
|
| Integrin alpha3beta1 | 1 | 2000 | 53 | 0.010 |
Why?
|
| Densitometry | 1 | 2000 | 151 | 0.010 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2001 | 192 | 0.010 |
Why?
|
| Motion | 1 | 2003 | 778 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 1694 | 0.010 |
Why?
|
| Heart Septum | 1 | 2001 | 303 | 0.010 |
Why?
|
| Quality of Life | 1 | 2021 | 13284 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 1996 | 4663 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2004 | 1078 | 0.010 |
Why?
|
| Linear Models | 2 | 2001 | 5876 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2019 | 5796 | 0.010 |
Why?
|
| Spine | 1 | 2006 | 1110 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 2002 | 698 | 0.010 |
Why?
|
| Endothelin-1 | 1 | 2000 | 301 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2004 | 1344 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2005 | 1612 | 0.010 |
Why?
|
| Pulmonary Edema | 1 | 2001 | 409 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 6070 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2005 | 2448 | 0.010 |
Why?
|
| Cognition | 1 | 2014 | 6940 | 0.010 |
Why?
|
| Temperature | 1 | 2003 | 2222 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1998 | 1631 | 0.010 |
Why?
|
| Safety | 1 | 2001 | 1149 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 1999 | 590 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2003 | 2698 | 0.010 |
Why?
|
| Toll-Like Receptor 4 | 1 | 1999 | 580 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2011 | 24049 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2004 | 4799 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 1998 | 932 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2004 | 2441 | 0.010 |
Why?
|
| Cell Death | 1 | 2000 | 1669 | 0.010 |
Why?
|
| Nitroprusside | 1 | 1994 | 273 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1999 | 4171 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 4286 | 0.010 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 1997 | 354 | 0.010 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2011 | 5247 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 1994 | 956 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2004 | 4353 | 0.010 |
Why?
|
| Thorax | 1 | 1994 | 553 | 0.010 |
Why?
|
| Heart Rate | 1 | 2001 | 4165 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2001 | 25860 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2000 | 3664 | 0.000 |
Why?
|
| Dopamine | 1 | 1994 | 1583 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 2011 | 13238 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 2004 | 21988 | 0.000 |
Why?
|
| Recurrence | 1 | 1997 | 8469 | 0.000 |
Why?
|
| Proportional Hazards Models | 1 | 1997 | 12522 | 0.000 |
Why?
|
| Boston | 1 | 1994 | 9274 | 0.000 |
Why?
|
| Retrospective Studies | 2 | 1995 | 80121 | 0.000 |
Why?
|